Emilio Arbe, MD

St. Pancras Clinical Research, London, United Kingdom

JCP
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
Original Research

June 3, 2026

Mebufotenin (GH001) demonstrated rapid and significant improvements in depressive symptoms and remission of postpartum depression.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe